ALK-positive Non-small Cell Lung Cancer Clinical Trials in Boston, Massachusetts
2 recruitingBoston, Massachusetts
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
ALK-Positive Lung CancerALK-positive Non-small Cell Lung CancerALK-positive NSCLC
TRIANA Biomedicines, Inc.160 enrolled9 locationsNCT07491497
Recruiting
Not Applicable
Patient-centered, Optimal Integration of Survivorship and Palliative Care
Carcinoma, Non-Small Cell LungSurvivorshipTargeted Therapy+5 more
Massachusetts General Hospital70 enrolled1 locationNCT04900935